A Repeat Dose Study to Investigate the Interaction of GSK2190915 on the Pharmacokinetics of Rosuvastatin

NCT01411111 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Rosuvastatin 10 mg
DRUG: GSK2190915 30mg
DRUG: GSK2190915 100mg

Sponsor

GlaxoSmithKline